S-acylation of influenza virus proteins: Are enzymes for fatty acid attachment promising drug targets?

Vaccine

Volumn 33, Issue 49, 2015, Pages 7002-7007

  Veit, Michael ^a   Siche, Stefanie ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

DHHC protein; Drug target; HA; Influenza virus; M2; Palmitoylation

Indexed keywords

2 (2 HYDROXY 5 NITRO BENZYLIDENE)BENZO[B]THIOPHEN 3 ONE; ACYLTRANSFERASE; ANTIVIRUS AGENT; FATTY ACID; PALMITIC ACID; STEARIC ACID; UNCLASSIFIED DRUG; VIRUS PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; STEARIC ACID DERIVATIVE;

ACYLATION; ARTICLE; CATALYSIS; DRUG TARGETING; HUMAN; INFLUENZA VIRUS; LUNG ALVEOLUS CELL; MEMBRANE FUSION; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN MODIFICATION; VIROGENESIS; VIRUS ASSEMBLY; VIRUS REPLICATION; ANIMAL; CHEMISTRY; DOG; LIPOYLATION; MDCK CELL LINE; MOUSE; ORTHOMYXOVIRIDAE; PHYSIOLOGY;

ACYLATION; ACYLTRANSFERASES; ANIMALS; DOGS; FATTY ACIDS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; LIPOYLATION; MADIN DARBY CANINE KIDNEY CELLS; MICE; ORTHOMYXOVIRIDAE; PALMITIC ACID; STEARIC ACIDS; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 84952639875     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.08.095     Document Type: Article

References (52)

1. Schmidt M.F. Acylation of viral spike glycoproteins: a feature of enveloped RNA viruses. Virology 1982, 116(1):327-338.
2. Veit M., Herrler G., Schmidt M.F., Rott R., Klenk H.D. The hemagglutinating glycoproteins of influenza B and C viruses are acylated with different fatty acids. Virology 1990, 177(Aug (2)):807-811.
3. Veit M., Kretzschmar E., Kuroda K., Garten W., Schmidt M.F., Klenk H.D., et al. Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutinin. J Virol 1991, 65(5):2491-2500.
4. Holsinger L.J., Shaughnessy M.A., Micko A., Pinto L.H., Lamb R.A. Analysis of the posttranslational modifications of the influenza virus M2 protein. J Virol 1995, 69(2):1219-1225.
5. Muraki Y., Okuwa T., Furukawa T., Matsuzaki Y., Sugawara K., Himeda T., et al. Palmitoylation of CM2 is dispensable to influenza C virus replication. Virus Res 2011, 157(Apr (1)):99-105.
6. Rossman J.S., Jing X., Leser G.P., Lamb R.A. Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 2010, 142(Sep (6)):902-913.
7. Sugrue R.J., Belshe R.B., Hay A.J. Palmitoylation of the influenza A virus M2 protein. Virology 1990, 179(Nov (1)):51-56.
8. Veit M., Klenk H.D., Kendal A., Rott R. The M2 protein of influenza A virus is acylated. J Gen Virol 1991, 72(Pt 6):1461-1465.
9. Hatta M., Kawaoka Y. The NB protein of influenza B virus is not necessary for virus replication in vitro. J Virol 2003, 77(May (10)):6050-6054.
10. Demers A., Ran Z., Deng Q., Wang D., Edman B., Lu W., et al. Palmitoylation is required for intracellular trafficking of influenza B virus NB protein and efficient influenza B virus growth in vitro. J Gen Virol 2014, 95(Pt 6):1211-1220.
11. Kordyukova L.V., Serebryakova M.V., Baratova L.A., Veit M. S acylation of the hemagglutinin of influenza viruses: mass spectrometry reveals site-specific attachment of stearic acid to a transmembrane cysteine. J Virol 2008, 82(Sep (18)):9288-9292.
12. Kordyukova L.V., Serebryakova M.V., Polyansky A.A., Kropotkina E.A., Alexeevski A.V., Veit M., et al. Linker and/or transmembrane regions of influenza A/Group-1 A/Group-2, and type B virus hemagglutinins are packed differently within trimers. Biochim Biophys Acta 2011, 1808(7):1843-1854.
13. Brett K., Kordyukova L.V., Serebryakova M.V., Mintaev R.R., Alexeevski A.V., Veit M. Site-specific S-acylation of influenza virus hemagglutinin: the location of the acylation site relative to the membrane border is the decisive factor for attachment of stearate. J Biol Chem 2014, 289(Dec (50)):34978-34989.
14. Naeve C.W., Williams D. Fatty acids on the A/Japan/305/57 influenza virus hemagglutinin have a role in membrane fusion. Embo J 1990, 9(12):3857-3866.
15. Sakai T., Ohuchi R., Ohuchi M. Fatty acids on the A/USSR/77 influenza virus hemagglutinin facilitate the transition from hemifusion to fusion pore formation. J Virol 2002, 76(May (9)):4603-4611.
16. Wagner R., Herwig A., Azzouz N., Klenk H.D. Acylation-mediated membrane anchoring of avian influenza virus hemagglutinin is essential for fusion pore formation and virus infectivity. J Virol 2005, 79(May (10)):6449-6458.
17. Chen B.J., Takeda M., Lamb R.A. Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly. J Virol 2005, 79(Nov (21)):13673-13684.
18. Engel S., Scolari S., Thaa B., Krebs N., Korte T., Herrmann A., et al. FLIM-FRET and FRAP reveal association of influenza virus haemagglutinin with membrane rafts. Biochem J 2010, 425(Feb):567-573.
19. Levental I., Grzybek M., Simons K. Greasing their way: lipid modifications determine protein association with membrane rafts. Biochemistry 2010, 49(Aug (30)):6305-6316.
20. Melkonian K.A., Ostermeyer A.G., Chen J.Z., Roth M.G., Brown D.A. Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts Many raft proteins are acylated, while few are prenylated. J Biol Chem 1999, 274(Feb (6)):3910-3917.
21. Hess S.T., Gould T.J., Gudheti M.V., Maas S.A., Mills K.D., Zimmerberg J. Dynamic clustered distribution of hemagglutinin resolved at 40nm in living cell membranes discriminates between raft theories. Proc Natl Acad Sci USA 2007, 104(Oct (44)):17370-17375.
22. Leser G.P., Lamb R.A. Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA NA and M2 proteins. Virology 2005, 342(Nov (2)):215-227.
23. Bentz J., Mittal A. Architecture of the influenza hemagglutinin membrane fusion site. Biochim Biophys Acta 2003, 1614(Jul (1)):24-35.
24. Zurcher T., Luo G., Palese P. Mutations at palmitylation sites of the influenza virus hemagglutinin affect virus formation. J Virol 1994, 68(9):5748-5754.
25. Jin H., Subbarao K., Bagai S., Leser G.P., Murphy B.R., Lamb R.A. Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity. J Virol 1996, 70(3):1406-1414.
26. Ujike M., Nakajima K., Nobusawa E. Influence of acylation sites of influenza B virus hemagglutinin on fusion pore formation and dilation. J Virol 2004, 78(Nov (21)):11536-11543.
27. Veit M., Serebryakova M.V., Kordyukova L.V. Palmitoylation of influenza virus proteins. Biochem Soc Trans 2013, 41(Feb (1)):50-55.
28. Castrucci M.R., Hughes M., Calzoletti L., Donatelli I., Wells K., Takada A., et al. The cysteine residues of the M2 protein are not required for influenza A virus replication. Virology 1997, 238(Nov (1)):128-134.
29. Grantham M.L., Wu W.H., Lalime E.N., Lorenzo M.E., Klein S.L., Pekosz A. Palmitoylation of the influenza A virus M2 protein is not required for virus replication in vitro but contributes to virus virulence. J Virol 2009, 83(Sep (17)):8655-8661.
30. Thaa B., Tielesch C., Moller L., Schmitt A.O., Wolff T., Bannert N., et al. Growth of influenza A virus is not impeded by simultaneous removal of the cholesterol-binding and acylation sites in the M2 protein. J Gen Virol 2011, 93(Pt 2):282-292.
31. Rocks O., Gerauer M., Vartak N., Koch S., Huang Z.P., Pechlivanis M., et al. The palmitoylation machinery is a spatially organizing system for peripheral membrane proteins. Cell 2010, 141(Apr (3)):458-471.
32. Duncan J.A., Gilman A.G. Autoacylation of G protein alpha subunits. J Biol Chem 1996, 271(Sep (38)):23594-23600.
33. Kummel D., Heinemann U., Veit M. Unique self-palmitoylation activity of the transport protein particle component Bet3: a mechanism required for protein stability. Proc Natl Acad Sci USA 2006, 103(Aug (34)):12701-12706.
34. Lobo S., Greentree W.K., Linder M.E., Deschenes R.J. Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae. J Biol Chem 2002, 277(Oct (43)):41268-41273.
35. Roth A.F., Feng Y., Chen L., Davis N.G. The yeast DHHC cysteine-rich domain protein Akr1p is a palmitoyl transferase. J Cell Biol 2002, 159(Oct (1)):23-28.
36. Veit M., Schmidt M.F. Timing of palmitoylation of influenza virus hemagglutinin. FEBS Lett. 1993, 336(Dec (2)):243-247.
37. Blaskovic S., Adibekian A., Blanc M., van der Goot G.F. Mechanistic effects of protein palmitoylation and the cellular consequences thereof. Chem Phys Lipids 2014, 180(May):44-52.
38. Greaves J., Chamberlain L.H. DHHC palmitoyl transferases: substrate interactions and (patho)physiology. Trends Biochem Sci 2011, 36(5):245-253.
39. Linder M.E., Jennings B.C. Mechanism and function of DHHC S-acyltransferases. Biochem Soc Trans 2013, 41(Feb (1)):29-34.
40. Roth A.F., Wan J., Bailey A.O., Sun B., Kuchar J.A., Green W.N., et al. Global analysis of protein palmitoylation in yeast. Cell 2006, 125(Jun (5)):1003-1013.
41. Jennings B.C., Linder M.E. DHHC protein S-acyltransferases use similar ping-pong kinetic mechanisms but display different acyl-CoA specificities. J Biol Chem 2012, 287(Mar (10)):7236-7245.
42. Mitchell D.A., Mitchell G., Ling Y., Budde C., Deschenes R.J. Mutational analysis of Saccharomyces cerevisiae Erf2 reveals a two-step reaction mechanism for protein palmitoylation by DHHC enzymes. J Biol Chem 2010, 285(Dec (49)):38104-38114.
43. Watanabe T., Kawakami E., Shoemaker J.E., Lopes T.J., Matsuoka Y., Tomita Y., et al. Influenza virus-host interactome screen as a platform for antiviral drug development. Cell Host Microbe 2014, 16(Dec (6)):795-805.
44. Watanabe T., Watanabe S., Kawaoka Y. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 2010, 7(6):427-439.
45. Fukata Y., Fukata M. Protein palmitoylation in neuronal development and synaptic plasticity. Nat Rev Neurosci 2010, 11(3):161-175.
46. Chavda B., Arnott J.A., Planey S.L. Targeting protein palmitoylation: selective inhibitors and implications in disease. Expert Opin Drug Discov 2014, 9(9):1005-1019.
47. Ducker C.E., Draper J.M., Xia Z., Smith C.D. In vitro and cellular assays for palmitoyl acyltransferases using fluorescent lipidated peptides. Methods 2006, 40(Oct (2)):166-170.
48. Jennings B.C., Nadolski M.J., Ling Y., Baker M.B., Harrison M.L., Deschenes R.J., et al. 2-Bromopalmitate and 2-(2-hydroxy-5-nitro-benzylidene)-benzo[b]thiophen-3-one inhibit DHHC-mediated palmitoylation in vitro. J. Lipid Res. 2009, 50(2):233-242.
49. Bailey C.C., Zhong G., Huang I.C., Farzan M. IFITM-family proteins: 1. The cell's first line of antiviral defense. Annu Rev Virol 2014, Nov (1):261-283.
50. Veit M. Palmitoylation of virus proteins. Biol Cell 2012, 104(9):493-515.
51. Gonzalez Montoro A., Quiroga R., Valdez Taubas J. Zinc co-ordination by the DHHC cysteine-rich domain of the palmitoyltransferase Swf1. Biochem J 2013, 454(Sep (3)):427-435.
52. Howie J., Reilly L., Fraser N.J., Vlachaki Walker J.M., Wypijewski K.J., Ashford M.L., et al. Substrate recognition by the cell surface palmitoyl transferase DHHC5. Proc Natl Acad Sci USA 2014, 111(Dec (49)):17534-17539.